Dr. Lindsey Baden, MD

• Infectious Disease Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Albert Einstein College Of Medicine

  Medical School, 1992

• 586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies, 2021-12-04

• Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial, 2017-11-14

• Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials, 2021-04-15

• Risks Associated with Lentiviral Vector Exposures and Prevention Strategies, 2016-09-22

• Safety and Immunogenicity of an HIV-1GagDNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults, 2012-01-05

• Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration, 2010-05-01

• Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice, 2023-02-14

• Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients, 2010-10-13

• Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses, 2012-11-07

• Bacteriophage treatment of disseminated cutaneousMycobacterium chelonaeinfection, 2022-05-03

• The Cost-Effectiveness of Transplanting Hearts From Hepatitis C Infected Donors Into Uninfected Recipients, 2022-10-27

• Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial, 2022-02-10

• An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor-binding domain vaccine in aged mice, 2022-01-26

• Diversion of HIV-1 Vaccine-induced Immunity by gp41-Microbiota Cross-reactive Antibodies, 2015-07-30

• Galectin-3 enhances neutrophil motility and extravasation into the airways duringAspergillus fumigatus infection, 2020-08-04

• B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV, 2021-04-24

• Candida albicansCervical Lymphadenitis in Patients Who Have Acute Myeloid Leukemia, 2016-03-03

• Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults, 2023-02-15

• Humoral signatures of protective and pathological SARS-CoV-2 infection in children, 2021-02-12

• Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials, 2023-01-03

• 100. Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant, 2021-12-04

• Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults, 2023-07-13

• Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials, 2021-05-14

• Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study, 2020-09-30

• The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients, 2022-03-21

• Immunogenicity of Recombinant Modified Vaccinia Ankara Following a Single or Multi-dose Vaccine Regimen in Rhesus Monkeys, 2009-01-23

• The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human eldersin vitroand aged micein vivo, 2022-12-21

• Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults, 2017-07-20

• Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients, 2010-07-21

• An Avid Imitator, 2016-01-26

• 24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients, 2021-12-04

• Risk factors for invasive fungal disease in heart transplant recipients, 2014-10-02

• Is the BCG Vaccine an Answer to Future Pandemic Preparedness?, 2022-01-27

• Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial, 2016-02-02

• Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial, 2022-10-06

• Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain, 2021-12-02

• 25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients, 2021-12-04

• Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals, 2015-05-23

• Invasive Yeast Infection After Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome, 2022-05-06

• Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system, 2022-06-17

• Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest, 2022-12-19

• Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice, 2023-03-03

• The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays, 2009-01-13

• Poxvirus Vectored CMV Vaccine to Prevent CMV Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial, 2020-02-11

• Dissecting polyclonal vaccine-induced humoral immunity against HIV using Systems Serology, 2015-11-05

• Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration, 2023-06-17

• Structural basis for continued antibody evasion by the SARS-CoV-2 receptor-binding domain, 2022-01-21

• Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results, 2023-08-31

• US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19, 2021-12-07

• Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial, 2019-11-20

• A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204), 2011-08-03

• 94. Infectious Complications of Left Ventricular Assist Devices, 2021-12-04

• Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial, 2023-04-19

• 996. CD4+ T-Cell Lymphopenia Associated with Frequent Plateletpheresis in Healthy Donors, 2021-12-04

• International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations, 2011-05-25

• Post-diagnostic Kinetics of the (1?3)-ß-D-Glucan Assay in Invasive Aspergillosis, Invasive Candidiasis, andPneumocystis jiroveciiPneumonia, 2012-03-08

• Effect of Immunization with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax, 2010-05-01

• Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria, 2008-09-01

• Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia, 2015-11-24

• Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial, 2023-08-28

• Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients, 2019-04-03

• Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial, 2021-11-23

• Age-specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1-polarization, 2016-10-28

• Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19, 2023-08-23

• Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study, 2019-08-08

• Cord-blood hematopoietic stem-cell transplantation confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis, 2012-05-04

• Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial Durability of Protection Against Symptomatic COVID-19 in Vaccine Trial Participants, 2022-06-08

• SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination, 2022-01-26

• Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain, 2021-06-22

• Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial, 2023-03-31

• Preexisting memory CD4+T cells contribute to the primary response in an HIV-1 vaccine trial, 2021-12-01